Satellos Bioscience Inc T.MSCL

Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > BND Projects Inc.

<< Previous

Bullboard Posts

Next >>

Post by Drambueyon Nov 12, 2021 6:23pm

321 Views

Post# 34121945

BND Projects Inc.

So on October 27 it was annouced that BND Projects Inc. at a cost of $10,000 per month, would be on the job and in charge of investor relations and on that day the stock closed at $1.50. Today we closed at $1.32 down 12% since BND has been on the job. Well at least they will never exercise their options at $1.48 what a fn joke this is and continues to be.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant